Dyne Therapeutics Stock Performance

Dyne Therapeutics Relative Risk vs. Return Landscape

If you would invest  2,355  in Dyne Therapeutics on October 30, 2025 and sell it today you would lose (551.00) from holding Dyne Therapeutics or give up 23.4% of portfolio value over 90 days. Dyne Therapeutics is generating negative expected returns assuming volatility of 4.8127% on return distribution over 90 days investment horizon. In other words, 43% of stocks are less volatile than Dyne, and above 99% of all equities are expected to generate higher returns over the next 90 days.Considering the 90-day investment horizon Dyne Therapeutics is expected to under-perform the market. In addition to that, the company is 6.38 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Dyne Therapeutics Target Price Odds to finish over Current Price

Considering the 90-day investment horizon the stock has the beta coefficient of 1.37 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Dyne Therapeutics will likely underperform. Additionally Dyne Therapeutics has an alpha of 0.2549, implying that it can generate a 0.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Dyne Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dyne Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 13.27 18.04 22.81 Details

Intrinsic Valuation Low Real High 13.04 17.81 22.58 Details

Naive Forecast Low Next High 12.97 17.75 22.52 Details

14 Analysts Consensus Low Target High 35.60 39.12 43.43 Details

Dyne Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Dyne Therapeutics is not an exception. The market had few large corrections towards the Dyne Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Dyne Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Dyne Therapeutics within the framework of very fundamental risk indicators.

Dyne Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Dyne Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Dyne Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Dyne Therapeutics Price Density Drivers

Dyne Therapeutics Fundamentals Growth

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.